Home Helex

Helex

In operation
Seed Round Financing
Novel Targeted Drug Developer
Basic
Enterprise Profile

Basic Information

Helex is a therapeutic company leveraging its proprietary LNP drug delivery and AI-based drug design platform to develop a new class of targeted drugs for hereditary kidney diseases. Helex has a team of world-class scientists and drug developers, operating in ASPIRE BioNEST in New York, USA, and Hyderabad, India, and is supported by Bayer Laboratories in Cambridge.
Helex Inc.
NewYork,NewYork,United States of America
15~50 people
January 01, 2021
contact@helex.bio

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Biological Drug Production
Technology
Artificial Intelligence Gene Editing Targeted Technology
Concept
Therapeutic Products
Application Scenarios
Targeted drugs Innovative Drugs AI+Pharmaceuticals